Vireo Growth Inc. (VREOF) stock
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $406.23MP/E –Yield –
Vireo Growth free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Vireo Growth's free cash flow for the twelve months ending Jun 30, 2026 was -$116.31M. For fiscal 2025 it was -$24.61M. The highest annual figure on record is -$5.93M in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$24.61M | – |
| FY2024 | Dec 31, 2024 | -$21.93M | – |
| FY2023 | Dec 31, 2023 | -$5.93M | – |
| FY2022 | Dec 31, 2022 | -$23.63M | – |
| FY2021 | Dec 31, 2021 | -$48.56M | – |
| FY2020 | Dec 31, 2020 | -$19.38M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$105.80M | – |
| Q1 FY2026 | Mar 31, 2026 | $1.10M | – |
| Q4 FY2025 | Dec 31, 2025 | $8.79M | – |
| Q3 FY2025 | Sep 30, 2025 | -$20.41M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.50M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.16M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.48M | -597.5% |
| Q2 FY2024 | Jun 30, 2024 | -$3.20M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.09M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.79M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.50M | – |
| Q2 FY2023 | Jun 30, 2023 | -$647.27K | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.99M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.74M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.13M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.83M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.93M | – |
| Q4 FY2021 | Dec 31, 2021 | -$11.20M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.84M | – |
| Q2 FY2021 | Jun 30, 2021 | -$18.62M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.90M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.80M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.68M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.65M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.24M | – |
See a number that looks wrong?